Bio-Equity 2025

by Alix Archer

Sebastien Stoitzner will be attending BioEquity

Bioequity 2025 GenSearch
We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges this May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”

Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel

by Alix

We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.

A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Read more “Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel”

Sébastien Stoitzner and Thibault Vercoutere Attend the Health Innovation Agency’s CAP Tour – Marseille Stop

by Alix
Agence-de-linnovation-en-sante-Posts-LinkedIn
Sébastien Stoitzner and Thibault Vercoutere will be attending the Tour de France of the Health Innovation Agency (Agence de l’Innovation en Santé – AIS), with a key stop in Marseille on 29th April 2025. Organised in collaboration with Eurobiomed, this regional stage of the national CAP Tour is designed to foster dialogue, showcase regional strengths, and accelerate the pace of healthcare innovation.

Read more “Sébastien Stoitzner and Thibault Vercoutere Attend the Health Innovation Agency’s CAP Tour – Marseille Stop”

HealthTech Dinner – Basel

by Alix
Heiko Bruhn Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle Nestle

At the HealthTech Dinner last week, hosted by GenSearch and PwC Switzerland and, we gathered to explore one of today’s most impactful topics in healthcare: Transforming the future of obesity care.

The evening brought together brilliant minds in Pharma and Life Sciences, with insights shared by Sule Erdim Ersoy from Novo Nordisk and Hans-Juergen Woerle from Nestlé Health Science.

Read more “HealthTech Dinner – Basel”